December 15, 2006

BILLS, BILLS, BILLS

 

House Passes Senate Bill (S. 3678) “Pandemic and All-Hazards Preparedness Act”
Prior to Congress adjourning on December 9, 2006, the House passed by unanimous consent S. 3678, the Pandemic and All-Hazards Preparedness Act, a bill to authorize funding to
biotechnology firms developing drugs and vaccines for bioterrorism-related illnesses and infectious diseases. The money is intended to help companies through the so called “Valley of Death,” a period in the start-up process when they need to conduct costly research and scale-up manufacturing capabilities but don’t yet have products that translate into government contracts or private investment.
 

Among its many provisions, S. 3678 would require establishment within HHS of a Biomedical Advanced Research and Development Authority (BARDA) to serve as a single point of authority in the Federal Government for civilian medical countermeasure advanced research and development as well as a strategic plan for countermeasure research, development and procurement. In July 2006, FASEB applauded establishment of BARDA. The bill would also require the Secretary’s National Science Advisory Board for Biosecurity, administered by NIH’s Office of Biotechnology Activities, to provide when requested by the Secretary, advice, guidance, or recommendations to relevant Federal departments and agencies on biological containment laboratory worker training and periodic evaluations of such laboratories. The Senate passed the measure on December 5th.

TOP OF PAGE

 


POLICY NEWS

 

NIH Announces New Fiscal Policies for FY2007 Grant Awards
The National Institutes of Health (NIH) issued a notice on December 15th, outlining its
plans for dealing with the flat funding and increased numbers of applications in FY2007.
According to the notice, NIH will cease to make inflationary increases for non-competing
renewal awards or modular grants. Based on programmatic or scientific priorities,
institutes and centers (ICs) will have the flexibility to supplement these awards on a case by case basis. The money saved from eliminating the inflationary increase will be put towards an estimated 9, 600 new and competing research project grants (RPGs). These RPGs will be prioritized, with ICs first considering new investigators, followed by first time grantees seeking their first renewal, then established grantees with insufficient other support. Finally, ICs will have some flexibility, again based on programmatic and
scientific priorities. All of these will be dependent, of course, on the applicant having a
review score near the payline of the relevant IC. For more information, please see:
http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-07-030.html

 

TOP OF PAGE

 


CONGRESSIONAL SCHEDULE

 

The House and Senate adjourned, ending the 109th Congress. The 110th Congress will
convene on January 2, 2006.

 

TOP OF PAGE

 

PAGE 1PAGE 2

 

GO BACK TO DEC 15, WASHINGTON UPDATE

 

FASEB’s Washington Update is brought to you bi-monthly by the FASEB Office of Public Affairs. We welcome your questions and comments – please contact Carrie Wolinetz at cwolinetz@faseb.org or 301-634-7650. For more information about how to get involved in research advocacy, visit: http://capwiz.com/faseb/home/

 

   
   
 

Click Here to
Subscribe/Unsubscribe to FASEB Washington Update